BioLineRx Ltd. American Depositary Shares (BLRX)

About BioLineRx Ltd. American Depositary Shares (BLRX)

BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.

BioLineRx Ltd. American Depositary Shares News